Search Result "tyrosine kinase inhibitors"


Review Article

A Concise Review on Tyrosine Kinase Targeted Cancer Therapy

Journal: Current Drug Therapy
Volume: 17 Issue: 2 Year: 2022 Page: 96-107
Author(s):

Review Article

Next-generation Bruton’s Tyrosine Kinase (BTK) Inhibitors PotentiallyTargeting BTK C481S Mutation- Recent Developments and Perspectives

Journal: Current Topics in Medicinal Chemistry
Volume: 22 Issue: 20 Year: 2022 Page: 1674-1691
Author(s):

Review Article

Molecular Mechanisms of Resistance to Tyrosine Kinase Inhibitors Associatedwith Hepatocellular Carcinoma

Journal: Current Cancer Drug Targets
Volume: 22 Issue: 6 Year: 2022 Page: 454-462
Author(s):

Review Article

Role of Fyn Kinase Inhibitors in Switching Neuroinflammatory Pathways

Journal: Current Medicinal Chemistry
Volume: 29 Issue: 2 Year: 2022 Page: 4738-4755
Author(s): Giambattista Marotta,Filippo Basagni,Michela Rosini,Anna Minarini

Review Article

Targeting Janus Kinase (JAK) for Fighting Diseases: The Research ofJAK Inhibitor Drugs

Journal: Current Medicinal Chemistry
Volume: 29 Issue: 2 Year: 2022 Page: 5010-5040
Author(s):

Review Article

Bruton's Tyrosine Kinase Inhibition in the Treatment of Preclinical Modelsand Multiple Sclerosis

Journal: Current Pharmaceutical Design
Volume: 28 Issue: 6 Year: 2022 Page: 437-444
Author(s): Anja Steinmaurer,Isabella Wimmer,Thomas Berger,Paulus S Rommer,Johann Sellner

Research Article

Identification of Multi-kinase Allosteric Inhibitors of Oncogenic TargetsEGFR1, PI3K, and BRAF Kinase

Journal: Current Computer-Aided Drug Design
Volume: 18 Issue: 7 Year: 2022 Page: 506-518
Author(s): Kavita Kumari Kakarala

Research Article

SAR131675 Receptor Tyrosine Kinase Inhibitor Induces Apoptosis through Bcl- 2/Bax/Cyto c Mitochondrial Pathway in Human Umbilical Vein Endothelial Cells

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 22 Issue: 5 Year: 2022 Page: 943-950
Author(s): Zeinab Babaei,Mojtaba Panjehpour,Hadi Parsian,Mahmoud Aghaei

Review Article

Entrectinib: A New Selective Tyrosine Kinase Inhibitor Approved forthe Treatment of Pediatric and Adult Patients with NTRK Fusionpositive,Recurrent or Advanced Solid Tumors

Journal: Current Medicinal Chemistry
Volume: 29 Issue: 1 Year: 2022 Page: 2602-2616
Author(s): Meral Tuncbilek,Hind M. Osman

Review Article

Recent Advances in Epidermal Growth Factor Receptor Inhibitors (EGFRIs) andtheir Role in the Treatment of Cancer: A Review

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 22 Issue: 20 Year: 2022 Page: 3370-3381
Author(s): Ananda Kumar Chettupalli,Mohammad Amjad Kamal

Previous   Next

Go To   Results 1 - 1 of 307

Filter Result

Volume Year
Content Type
Ads
© 2024 Bentham Science Publishers | Privacy Policy